SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-16-104933
Filing Date
2016-03-14
Accepted
2016-03-14 16:27:30
Documents
8
Period of Report
2016-05-25

Document Format Files

Seq Description Document Type Size
1 PRE 14A a16-6292_1pre14a.htm PRE 14A 477598
2 GRAPHIC g62921bii001.jpg GRAPHIC 1947
3 GRAPHIC g62921bii002.jpg GRAPHIC 1965
4 GRAPHIC g62921bii003.jpg GRAPHIC 2060
5 GRAPHIC g62921bii004.jpg GRAPHIC 2025
6 GRAPHIC g62921bii005.gif GRAPHIC 1870
7 GRAPHIC g62921cai001.gif GRAPHIC 75935
8 GRAPHIC g62921cai002.gif GRAPHIC 33230
  Complete submission text file 0001104659-16-104933.txt   643572
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37526 | Film No.: 161504174
SIC: 2834 Pharmaceutical Preparations